Form 4: Microbot Medical Director Acquires Stock Options
SEC Form 4 Filing
Martin J. Madden, a director of Microbot Medical Inc., reports the acquisition of stock options.
Summary
- On January 28, 2025, Martin J. Madden, a director of Microbot Medical Inc., acquired 10,000 stock options with an exercise price of $1.93.
- These options are exercisable starting December 17, 2025, and expire on January 28, 2035.
- Following this transaction, Madden directly owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option acquisition by a director.
Industry Context
This is a standard SEC Form 4 filing, indicating a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director could be perceived positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of transaction: Director acquired stock options. |
| 12/17/2025 | Date exercisable: Stock options become exercisable. |
| 01/28/2035 | Expiration date: Stock options expire. |
| 01/29/2025 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.